Simple Physical Exercise With Instant Messaging Support for Smoking Via "Quit to Win" Contest 2022 (QTW2022)

August 9, 2023 updated by: Dr. Wang Man-Ping, The University of Hong Kong

Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2022: Simple Physical Exercise With Instant Messaging Support for Smoking Cessation

This project aims to test the effectiveness of an integrated intervention of brief cessation advice (AWARD) and simple physical exercise with Instant Messaging (IM) support compared with control participants among current smokers who joined the contest.

Study Overview

Detailed Description

Although smoking prevalence is decreasing in Hong Kong, it accounts for over 7,000 deaths per year and a large amount of medical cost, long-term care, and productivity loss of US$ 688 million (0.6% Hong Kong GDP). Quitting is difficult because nicotine is highly addictive. Long-term habitual tobacco smoking could foster a series of physical and psychological dependence on nicotine, and thus induce cravings and nicotine withdrawal symptoms when remaining abstinent.

In addition to pharmacotherapy and behavioral counseling, exercise has shown promising effects on reducing craving, cigarette consumption, withdrawal symptoms, and increasing intention and attempt to quit. Randomized trials on smoking cessation have shown that vigorous or moderate exercise (including aerobics, brisk walking, and weightlifting) increases tobacco abstinence. However, these exercise-based smoking cessation trials were small-scaled with sample sizes ranging from 20 to 543, and mainly targeted the smokers who were motivated to quit (active treatment seekers). Most (15/20) of the vigorous or moderate exercises adopted in the smoking cessation trials required the participants to attend multiple exercise sessions (at least weekly for 5 months) under supervision or self-monitoring using equipment (e.g., pedometers) with a low proportion (<50%) of the participants achieved targeted level of attendance and exercise. The effects were short-term (end of treatment) and long-term (6 months or above) effects were uncertain, and cannot be generated in smokers who had low motivation to quit.

Mobile health (mHealth) is now a part of the World Health Organization's (WHO) strategies on combating smoking (http://www.who.int/tobacco/mhealth/en/) and has been used in many countries given its low cost and popular use. Instant messaging (IM) applications (apps) (e.g., WhatsApp, WeChat) are compatible with smartphones and allow sending interactive messages such as text, photos, video, animation, and files. The widespread availability of IM apps allows healthcare professionals to deliver health information and behavioral interventions through messaging. The QTW Contest 2017 using chat-based psychosocial support through IM apps effectively increased short-term (end of treatment, 3 months) and long-term (6 months since intervention initiation) smoking abstinence.

The chat-based IM support has the potential to support the use of other treatment components. The investigators aimed to test (1) the effectiveness of an integrated intervention of brief cessation advice (AWARD), simple physical exercise with Instant Messaging (IM) support compared with control participants among current smokers; (2) to explore participants' experience and perceptions towards the intervention.

Study Type

Interventional

Enrollment (Actual)

1031

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hong Kong
      • Hong Kong, Hong Kong, China, 852
        • Hong Kong Council on Smoking and Health (COSH)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hong Kong residents aged 18 or above
  • Smoke at least 1 tobacco stick (includes HTP) per day or use e-cigarette daily in the preceding 3-month
  • Able to communicate in Chinese (including reading Chinese in IM)
  • Saliva cotinine 30 ng/ml or above
  • Intent to quit / reduce smoking
  • Able to use the instant messaging tool (e.g., WhatsApp, WeChat) for communication.

Exclusion Criteria:

  • Smokers who have communication barriers (either physically or cognitively)
  • Smokers who are currently participating in other SC programmes or services

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brief cessation advice (AWARD) + simple physical exercise with Instant Messaging (IM) support
The integrated intervention of brief cessation advice (AWARD), and simple physical exercise practices with Instant Messaging (IM) support for craving management
Ask about smoking history, Warn about the high risk of smoking, Advise to quit as soon as possible, Refer to the smoking cessation services, and Do it again (if the smokers refused to set quit date).
The content consists of brief information and highlights of existing smoking cessation services, contact methods, motivation information, and strong supporting messages or slogans.
The contents include information about the benefits of quitting, smoking and diseases, methods to quit, how to handle withdrawal symptoms, declaration of quitting, etc.
The simple exercises consist of a) Zero-time exercises (ZTEx), b) handgrip exercises, and c) resistance exercises. Participants will receive handgrips and elastic bands, and trained smoking cessation ambassadors will demonstrate and encourage the use of handgrip and elastic bands onsite with an instruction leaflet.
During the 3-month instant messaging support, smoking cessation counselors will deliver regular messages to encourage the practices of simple physical exercise, provide strategies for managing craving and withdrawal symptoms, and provide information on smoking-related knowledge and available smoking cessation services. Our trained smoking cessation counselors will also provide real-time support upon participants' inquiries.
Active Comparator: Brief cessation advice (AWARD)
Ask about smoking history, Warn about the high risk of smoking, Advise to quit as soon as possible, Refer to the smoking cessation services, and Do it again (if the smokers refused to set quit date).
The content consists of brief information and highlights of existing smoking cessation services, contact methods, motivation information, and strong supporting messages or slogans.
The contents include information about the benefits of quitting, smoking and diseases, methods to quit, how to handle withdrawal symptoms, declaration of quitting, etc.
SMS on follow-up survey reminders

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemically validated abstinence
Time Frame: 3-month follow-up
Defined as exhaled CO level <4ppm and saliva cotinine level ≤30 ng/ml
3-month follow-up
Biochemically validated abstinence
Time Frame: 6-month follow-up
Defined as exhaled CO level <4ppm and saliva cotinine level ≤30 ng/ml
6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking quit rate change from baseline at 3-month follow-up
Time Frame: 3-month follow-up
Self-reported 7-day point prevalence (pp) quit rate at 3-month between the two groups
3-month follow-up
Smoking quit rate change from baseline at 6-month follow-up
Time Frame: 6-month follow-up
Self-reported 7-day point prevalence (pp) quit rate at 6-month between the two groups
6-month follow-up
Smoking reduction rate change from baseline at 3-month follow-up
Time Frame: 3-month follow-up
Rate of smoking reduction by at least half of baseline amount in the two groups
3-month follow-up
Smoking reduction rate change from baseline at 6-month follow-up
Time Frame: 6-month follow-up
Rate of smoking reduction by at least half of baseline amount in the two groups
6-month follow-up
Physical exercise level
Time Frame: 3-month follow-up
Measured by international physical activity questionnaire - short form (IPAQ-SF). The scale assesses the types and intensity of physical activity and sitting time that people do as part of their daily lives (during the last 7 days) are considered to estimate total physical activity in metabolic equivalent of task (MET)-min/week and time spent sitting.
3-month follow-up
Physical exercise level
Time Frame: 6-month follow-up
Measured by international physical activity questionnaire - short form(IPAQ-SF). The scale assesses the types and intensity of physical activity and sitting time that people do as part of their daily lives (during the last 7 days) are considered to estimate total physical activity in metabolic equivalent of task (MET)-min/week and time spent sitting.
6-month follow-up
Intervention compliance at the end of treatment at 3 months follow-up
Time Frame: 3-month follow-up
Rate of self-reported practice and frequency of simple physical exercise, IM engagement (replied for at least 2 messages confirmed by the conversation log)
3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Man Ping Wang, PhD, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 18, 2022

Primary Completion (Estimated)

September 30, 2023

Study Completion (Estimated)

December 31, 2023

Study Registration Dates

First Submitted

June 16, 2022

First Submitted That Met QC Criteria

June 19, 2022

First Posted (Actual)

June 24, 2022

Study Record Updates

Last Update Posted (Actual)

August 14, 2023

Last Update Submitted That Met QC Criteria

August 9, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • QTW2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on AWARD advice

3
Subscribe